Results 1 to 10 of about 1,192 (156)

SUV39H1 maintains cancer stem cell chromatin state and properties in glioblastoma

open access: yesJCI Insight
Glioblastoma (GBM) is the most lethal brain cancer, with GBM stem cells (GSCs) driving therapeutic resistance and recurrence. Targeting GSCs offers a promising strategy for preventing tumor relapse and improving outcomes. We identify SUV39H1, a histone-3,
Chunying Li   +12 more
doaj   +4 more sources

Age-Associated Decrease of the Histone Methyltransferase SUV39H1 in HSC Perturbs Heterochromatin and B Lymphoid Differentiation

open access: yesStem Cell Reports, 2016
Summary: The capacity of hematopoietic stem cells (HSC) to generate B lymphocytes declines with age, contributing to impaired immune function in the elderly.
Dounia Djeghloul   +13 more
doaj   +2 more sources

Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. [PDF]

open access: yesPLoS ONE, 2008
Modifications of the histone amino-terminal tails affect access of regulatory factors and complexes to chromatin and thereby influence biological processes.
Yutaka Kondo   +6 more
doaj   +1 more source

Rhoifolin Alleviates Ulcerative Colitis by Targeting NMNAT1 and Activating SIRT1‐FOXO1 Signaling to Enhance ILC3s Effector Function

open access: yesAdvanced Science, Volume 13, Issue 60, 28 October 2026.
Rhoifolin directly targets NMNAT1, thereby activating nicotinamide salvage pathway and promoting intracellular NAD+ biosynthesis. Elevated NAD+ levels enhance SIRT1 activity, leading to FOXO1 deacetylation and nuclear translocation. Nuclear FOXO1 subsequently binds to the IL‐22 promoter, upregulating IL‐22 transcription and potentiating ILC3 effector ...
Hongqiong Yang   +12 more
wiley   +1 more source

H3K9me3 inhibition reverses Alzheimer's progression by restoring synaptic and immune proteostasis across the brain–retina axis

open access: yesAlzheimer's &Dementia, Volume 22, Issue 10, October 2026.
Abstract INTRODUCTION Epigenetic dysregulation is increasingly linked to aging and neurodegeneration, yet its contribution to retinal and brain pathology in Alzheimer's disease (AD) remains unclear. METHODS We quantified the repressive epigenetic mark histone H3 lysine 9 trimethylation (H3K9me3) in post mortem retinas and brains from donors spanning ...
Dieu‐Trang Fuchs   +20 more
wiley   +1 more source

Structural insights into the recognition of endogenous nucleosomes by the human SUV39H1- HP1α complex

open access: yesShanghai Jiaotong Daxue xuebao. Yixue ban
Objective·To analyze the three-dimensional structure of the human histone methyltransferase SUV39H1 in complex with heterochromatin protein 1α bound to the endogenous nucleosome core particle (NCPendo) through cryo-electron microscopy (cryo-EM).Methods ...
Hu Qiong, Huang Jing
doaj   +1 more source

Kinetic Control of Condensate Function: How the Formation Dynamics of APBs Influence ALT Cancer Telomere Length Heterogeneity

open access: yesBioEssays, Volume 48, Issue 10, October 2026.
The dynamics of PML body formation at telomeres in cancer cells using the alternative lengthening of telomeres (ALT) pathway for telomere elongation correlate with different degrees of ALT activity and might contribute to telomere length heterogeneity in ALT cancer cells.
Huaiying Zhang
wiley   +1 more source

Beyond Exhaustion: The RNA Regulatory Layer of Tissue‐Instructed T Cell Dysfunction

open access: yesEuropean Journal of Immunology, Volume 56, Issue 10, October 2026.
CD8+ T cell dysfunction arises through classical exhaustion after priming by professional antigen‐presenting cells, and through extra‐lymphoid priming by non‐professional cells – exemplified by the liver, where hepatocyte priming yields a checkpoint‐refractory state.
Francesco Andreata   +3 more
wiley   +1 more source

Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma

open access: yesSignal Transduction and Targeted Therapy, 2023
TP53 mutation (TP53 mut) occurs in 10–20% of diffuse large B-cell lymphoma (DLBCL) cases and serves as an unfavorable biomarker of DLBCL progression.
Ying Fang   +11 more
doaj   +1 more source

Clinical Epigenomics in Rare Diseases: Interpreting DNA Methylation Episignatures

open access: yesMolecular Genetics &Genomic Medicine, Volume 14, Issue 10, October 2026.
Clinical epigenomics extends rare‐disease diagnostics beyond DNA sequence by revealing the downstream regulatory consequences of genetic variation. DNA methylation episignatures provide functional evidence that can support diagnosis, refine variant interpretation, distinguish overlapping disorders, and complement genomic, and multi‐omic testing ...
Himanshu Goel, Shuxiang Goh, Luke Stuart
wiley   +1 more source

Home - About - Disclaimer - Privacy